List of labelling kits for the preparation of a technetium-99m labelled bone scanning agent
1. Labelling kits containing methylenediphosphonic acid (MDP, medronic acid)
| Trade name | Firm | MDP | Reducing Agent | Others | Max. Activity | Shelf life (a) |
| SOLCO®SMDP | SOLMED/SORIN BIOMEDICAL | 25,0 mg | SnF2: 0,2 mg | Acidum aethylene-diamine-N, N, N\\\\\', N\\\\\'-tetrakis-methylene-phosphonicum: 0,8 mg | 550 MBq | 6 hours |
| Technetium Tc 99m Medronate | Bracco Diagnostics Inc. | 20,0 mg | SnF2: 0,13-0,38 mg | Ascorbic Acid: 1,0 mg NaOH: 11,0 mg |
740 MBq | |
| Technetium Tc99m Medronate For Injection | Mallinckrodt Inc. | 10,0 mg | SnCl2.H2O: 0,8 mg | p-aminobenzoic acid: 2,0 mg | 740 MBq in 2-10 ml | 6 hours |
| DRAXIMAGE MDP | DRAXIMAGE | 10,0 mg | SnF2: 1,1 mg | p-aminobenzoic acid: 2,0 mg | 740 MBq | 12 hours |
| Technetium[99mTc] Medronate Injection for Bone Scanning AUST R 14330 | Radpharm Scientific Pty.Ltd. | 10,0 mg | SnCl2.H2O: 1,0 mg | Ascorbic Acid: 1,0 mg | 16000 MBq | 8 hours |
| Technetium-99m Medronate Radiodiagnostic Reagent MDP-10, MDP-21 |
Edmonton Radiopharmaceutical Centre | 10,0 mg | SnCl2.H2O: 0,92 mg | Ascorbic Acid: 0,125 mg | 555 MBq | 12 hours |
| MEDROCIS%u2122 | Schering Health Care Ltd | 10,0 mg | SnCl2.H2O: 1,0 mg | Ascorbic Acid: 1,8 mg | 11,1 GBq | 8 hours |
| 8-MDP Kit NO. 88/105/93-C | Lacomed | 8,0 mg | SnCl2.H2O: 0,6 mg | 8 hours | ||
| 6-MDP Kit 88/105/93-C | Lacomed | 6,0 mg | SnCl2.H2O: 0,45 mg | Gentisic Acid: 1,0 mg | ||
| Amerscan Medronate II Technetium Agent | Amersham International plc | 5,0 mg | SnF2: 0,34 mg | p-aminobenzoic acid: 2,0 mg | 18-5 GBq | 8 hours |
| MDP Tc-IK-10 | Izotop, Institute of Isotopes Co. Ltd. | 5,0 mg | SnCl2.H2O: 0,6 mg | Ascorbic Acid: 0,5 mg Carbamide: 10,0 mg |
6000 MBq | 3 hours |
| 99mTc-MDP MTcK-8 - MTcK-8/3 |
POLATOM | 5,0 mg | SnCl2.H2O: 0,42 mg | Ascorbic Acid: 2,0 mg NaOH: 2,26 mg |
||
| LENOSCINT | NORDION EUROPE S.A. | 1,8 mg | SnCl2.H2O: 0,45 mg | Ascorbic Acid: 1,76 mg NaOH: 0,09-0,12 mg Sodium Chloride: 2,0 mg |
700 MBq | 8 hours |
| [99mTc]-MDP | ROTOP® Pharmaka GmbH | 5,0 mg | SnCl2.H2O: 0,48 mg | Ascorbic Acid: 0,5 mg | 11,1 GBq | 1 hour |
| IFE MDP TC.52S | ISOpharma | 10,0 mg | SnCl2.H2O: 0,3 mg | Gentisic Acid: 1,0 mg | 4 hours |
(a) shelf-life : the time during which the preparation may be used after labelling with technetium-99m
2. Labelling kits containing hydroxymethylenediphosphonic acid (HDP, oxidronic acid)
| Trade name | Firm | HDP | Reducing Agent | Others | Max. activity | Shelf life (a) |
| OSTEOCIS | Schering Health Care Limited | 3,0 mg | SnCl2.H2O: 0,45 mg | Ascorbic Acid: 0,75 mg | 11100 MBq | 6 hours |
| OSTEOCIS® PA 677/7/1 | ElectraMed | 3,0 mg | SnCl2.H2O: 0,45 mg | Ascorbic Acid: 0,75 mg | 11100 MBq | 8 hours |
| TCK-21 (b) | Schering Health Care Limited | 2,0 mg | SnCl2.H2O: 0,30 mg | Ascorbic Acid: 0,5 mg | 6 hours | |
| TechneScan® HDP | Mallinckrodt Inc. | 0,258 mg | SnCl2.H2O: 0,297-0,343 mg | Gentisic Acid: 0,84 mg | 11100 MBq | 8 hours |
(a) shelf-life : the time during which the preparation may be used after labelling with technetium-99m
(b) no longer available
3. Labelling kit containing 3,3-diphosphono-1,2-propanedicarboxylic acid, tetrasodium salt (DPD)
| Trade name | Firm | DPD | Reducing Agent | Others | Max. activity | Shelf life |
| TECEOS%u2122 | Schering Health Care Limited | 13,0 mg | 0,23 mg | Gentisic Acid: 1,0 mg | 11100 MBq | 8 hours |
4. Labelling kit containing 1-hydroxyethylidene-1,1-diphosphonic acid (HEDP, EHDP)
| Trade name | Firm | HEDP | Reducing Agent | Others | Max. activity | Shelf life |
| Phosphon in vivo kit (Tc-IK-1) | Izotop, Institute of Isotopes Co. Ltd. | 25,0 mg | SnCl2.H2O: 1,0 mg | NaCl 10,0 mg | 3700 MBq | 3 hours |